Recovery of neutrophil count by ganciclovir in patients with chronic idiopathic neutropenia associated with cytomegalovirus infection in bone marrow stromal cells

International Journal of Hematology

Volumn 79, Issue 4, 2004, Pages 337-339

  Hirayama, Yasuo ^a   Sakamaki, Sumio ^a   Tsuji, Yasushi ^a   Chiba, Hiroki ^b   Matsunaga, Takuya ^b   Takimoto, Rishu ^b   Kato, Junji ^b   Niitsu, Yoshiro ^b  

^a Higashi Sapporo Hospital   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytomegalovirus; Ganciclovir; Neutropenia; Stromal cell

Indexed keywords

GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; VIRUS DNA;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CASE REPORT; CHRONIC IDIOPATHIC NEUTROPENIA; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; NEUTROPENIA; NEUTROPHIL; STROMA CELL;

EID: 2942544112     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.03155     Document Type: Article

References (11)

1. Kyle RA, Linman JW. Chronic idiopathic neutropenia: a newly recognized entity? N Engl J Med. 1968;279:1015-1019.
2. Jakubowski AA, Souza L, Kelly F, et al. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med. 1989;320:38-42.
3. Kohgo Y, Hirayama Y, Matsunaga T, Kato J, Sakamaki S, Niitsu Y. Chronic idiopathic neutropenia associated with abnormal expression of granulocyte colony-stimulating factor mRNA of bone marrow stromal cells. Int J Hematol. 1994;59:177-180.
4. Papadaki HA, Giouremou K, Eliopoulous GD. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-β1 by bone marrow stromal cells. Eur J Haematol. 1999;63:154-162.
5. Papadaki HA, Coulocheri S, Eliopoulos GD. Patients with chronic idiopathic neutropenia of adults have increased serum concentration of inflammatory cytokines and chemokines. Am J Hematol. 2000;65:271-277.
6. Simmons P, Kaushansky K, Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA. 1990;87:1386-1390.
7. Suwansirikul S, Rao N, Dowking JN, Ho M. Primary and secondary cytomegalovirus infection: clinical manifestation after renal transplantation. Arch Intern Med. 1977;137:1026-1029.
8. Hirayama Y, Sakamaki S, Matsunaga T, et al. Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells. Blood. 1998;92:46-52.
9. Sakamaki S, Hirayama Y, Matsunaga T, et al. Transforming growth factor β1 (TGF-β31) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-β receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-β itself with high specificity. Blood. 1999;94:1961-1979.
10. Jiwa NM, van Gemert GW, Raap AK, et al. Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation. 1989;48:72-76.
11. Kyle RA. Natural history of chronic idiopathic neutropenia. N Engl J Med. 1980;302:908-909.